Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Business & Regulation Advanced Medicine, Standards & Regulation

FDA Accelerated Approval Pathways for Cell and Gene Therapy products

sponsored by Thermo Fisher Scientific

Available On-Demand

June 22, 2020 | 11am EDT / 4pm BST / 5pm CEST

The cell and gene therapy regulatory landscape is rapidly evolving. Join this webinar to discover the approaches available to this industry to accelerate the approval of cell and gene therapy products by discussing early FDA engagement opportunities, identifying the different approval pathways taken by the Agency to bring products to market quickly, and examining the recent cell and gene therapy guidances issued by the FDA.

Learning Objectives

  • Cell and gene therapy regulatory landscape.
  • The different types of FDA expedited pathways available.
  • Recent cell and gene therapy guidances issued.

Available On-Demand

Subscribe to The Medicine Maker Newsletters

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine